Omrix Biopharmaceuticals, Inc. — SC TO-T

Filed: 2008-11-25
Form: SC TO-T
Accession: 0000950123-08-016356
Registrant: Omrix Biopharmaceuticals, Inc.
CIK: 0001349426
Industry (SIC): Biological Products, (No Diagnostic Substances) (2836)
State of incorporation: DE
Location: NEW YORK, NY

Omrix Biopharmaceuticals, Inc. of NEW YORK, NY filed a SC TO-T with the SEC on 2008-11-25. Industry: Biological Products, (No Diagnostic Substances).

Filing

Seq	Type	Description
1	SC TO-T	SCHEDULE TO
2	EX-99.A.1.A	EX-99.A.1.A: OFFER TO PURCHASE
3	EX-99.A.1.B	EX-99.A.1.B: LETTER OF TRANSMITTAL
4	EX-99.A.1.C	EX-99.A.1.C: NOTICE OF GUARANTEED DELIVERY
5	EX-99.A.1.D	EX-99.A.1.D: LETTER TO BROKERS
6	EX-99.A.1.E	EX-99.A.1.E: LETTER TO CLIENTS
7	EX-99.A.5.B	EX-99.A.5.B: SUMMARY NEWSPAPER ADVERTISEMENT
8	EX-99.A.5.C	EX-99.A.5.C: PRESS RELEASE
9	EX-99.D.1	EX-99.D.1: AGREEMENT AND PLAN OF MERGER
10	EX-99.D.2	EX-99.D.2: TENDER AND SUPPORT AGREEMENT
11	EX-99.D.3	EX-99.D.3: LETTER AGREEMENT
12	EX-99.D.4	EX-99.D.4: LETTER AGREEMENT

Showing 12 of 18 filings.